Angela Vollstedt

Global Director, Cell & Gene Therapies Portfolio Management • Novartis

Angela Vollstedt, a seasoned professional in the pharmaceutical industry, boasts an impressive 15+ year international career marked by notable achievements. Her expertise encompasses leading pharmaceutical drug research and development, life-cycle management, and commercial manufacturing. Angela thrives on challenges and is deeply committed to driving operational excellence and innovation within fast-paced environments that demand strong business acumen and impeccable time management.

With a genuine passion for organizational growth, Angela has successfully collaborated with research scientists and executive leadership to translate cutting-edge scientific discoveries into tangible healthcare advancements. Her exceptional abilities in building robust relationships and fostering a healthy work environment have allowed her to leverage emotional intelligence and strategic thinking to facilitate constructive decision-making and open communication with C-suite executives and stakeholders at all levels.

Angela’s accomplishments in the fields of biologics, as well as cell and gene therapies research & development, are commendable. She has demonstrated a remarkable track record in delivering new medical products from early clinical development to market authorization applications and life-cycle management, while effectively managing multi-million-dollar budgets. Additionally, she has excelled in leading high-performing commercial manufacturing teams, ensuring timely customer satisfaction and preparing for successful health authority audits.

Also speaking

Angelo Raggioli

Head of Technology Development • ReiThera

Lynn Fischer

Chief Executive Officer • TITLE21 Health Solutions

Matthew Lakelin

Vice President, Scientific Affairs & Product Development, Co-Founder • Trakcel

Event Info


Sponsorship Opportunities Waiting List

Take a look at the sample attendee list for Advanced Therapies Europe 2023 here.


Find out more about partnering at Advanced Therapies Europe.